163 related articles for article (PubMed ID: 2582777)
1. Correction of the anaemia of chronic renal failure with erythropoietin: pharmacokinetic studies in patients on haemodialysis and CAPD.
Hughes RT; Cotes PM; Oliver DO; Pippard MJ; Royston P; Stevens JM; Strong CA; Tam RC; Winearls CG
Contrib Nephrol; 1989; 76():122-30. PubMed ID: 2582777
[No Abstract] [Full Text] [Related]
2. Subcutaneous recombinant erythropoietin in the treatment of renal anaemia in CAPD patients.
Macdougall IC; Cavill I; Davies ME; Hutton RD; Coles GA; Williams JD
Contrib Nephrol; 1989; 76():219-26. PubMed ID: 2582780
[No Abstract] [Full Text] [Related]
3. [The effect of hemodialysis and continuous ambulatory peritoneal dialysis on renal anemia].
Stojimirović B; Grujić-Adanja G
Srp Arh Celok Lek; 1997; 125(5-6):163-7. PubMed ID: 9265238
[TBL] [Abstract][Full Text] [Related]
4. Erythropoietin and peritoneal dialysis: the efficacy of intraperitoneal dosing.
Nissenson AR
Perit Dial Int; 1992; 12(4):350-2. PubMed ID: 1420491
[No Abstract] [Full Text] [Related]
5. Anemia and erythropoietin in hemodialysis and continuous ambulatory peritoneal dialysis.
Korbet SM
Kidney Int Suppl; 1993 Feb; 40():S111-9. PubMed ID: 8445832
[No Abstract] [Full Text] [Related]
6. Statement on the clinical use of recombinant erythropoietin in anemia of end-stage renal disease. Ad Hoc Committee for the National Kidney Foundation.
Am J Kidney Dis; 1989 Sep; 14(3):163-9. PubMed ID: 2672796
[No Abstract] [Full Text] [Related]
7. Subcutaneous erythropoietin in the treatment of renal anaemia.
Drinovec J; Varl J
Przegl Lek; 1992; 49(1-2):38-40. PubMed ID: 1455004
[TBL] [Abstract][Full Text] [Related]
8. Erythropoietin escape in five CAPD patients.
Williams P; Jones J
Nephron; 1996; 73(2):354. PubMed ID: 8773387
[No Abstract] [Full Text] [Related]
9. Treatment of anaemia in CAPD patients with recombinant human erythropoietin.
Ramello A; Malcangi U; Bruno M; Perosa P; Reina E; Rizzuto A; Nasini MG; Carozzi S
Adv Perit Dial; 1990; 6():308-11. PubMed ID: 1982834
[TBL] [Abstract][Full Text] [Related]
10. Stepwise correction of anaemia by subcutaneous administration of human recombinant erythropoietin in patients with chronic renal failure maintained by continuous ambulatory peritoneal dialysis.
Stevens JM; Auer J; Strong CA; Hughes RT; Oliver DO; Winearls CG; Cotes PM
Nephrol Dial Transplant; 1991; 6(7):487-94. PubMed ID: 1922910
[TBL] [Abstract][Full Text] [Related]
11. Pharmacokinetics of intravenous, intraperitoneal, and subcutaneous recombinant erythropoietin in patients on CAPD. A rationale for treatment.
Macdougall IC; Roberts DE; Neubert P; Dharmasena AD; Coles GA; Williams JD
Contrib Nephrol; 1989; 76():112-20; discussion 120-1. PubMed ID: 2684515
[No Abstract] [Full Text] [Related]
12. Recombinant human erythropoietin in patients on peritoneal dialysis.
Bargman J
Perit Dial Int; 1989; 9(4):245-6. PubMed ID: 2488375
[No Abstract] [Full Text] [Related]
13. The pharmacokinetics of intraperitoneal erythropoietin administered undiluted or diluted in dialysate.
Bargman JM; Jones JE; Petro JM
Perit Dial Int; 1992; 12(4):369-72. PubMed ID: 1420495
[TBL] [Abstract][Full Text] [Related]
14. Dialysis efficiency in continuous ambulatory peritoneal dialysis patients treated with erythropoietin.
Taylor JE; MacTier RA; Henderson IS; Belch JJ; Stewart WK
Perit Dial Int; 1992; 12(2):221-6. PubMed ID: 1586685
[TBL] [Abstract][Full Text] [Related]
15. Subcutaneous erythropoietin administration in predialysis patients: a single centre prospective study.
Branger B; Vécina F; Zabadani B; Balducchi JP; Fourcade J
Nephrol Dial Transplant; 1995; 10 Suppl 6():36-9. PubMed ID: 8524492
[TBL] [Abstract][Full Text] [Related]
16. [Erythropoietin treatment in children with chronic renal failure].
Ito K; Hattori M
Nihon Rinsho; 1991 Dec; 49 Suppl():688-94. PubMed ID: 1808336
[No Abstract] [Full Text] [Related]
17. Pharmacokinetics of recombinant human erythropoietin in children treated with continuous ambulatory peritoneal dialysis.
Reddingius RE; Schröder CH; Koster AM; Monnens LA
Eur J Pediatr; 1994 Nov; 153(11):850-4. PubMed ID: 7843202
[TBL] [Abstract][Full Text] [Related]
18. Effect of human recombinant erythropoietin on anaemia and dialysis efficiency in patients undergoing continuous ambulatory peritoneal dialysis.
Steinhauer HB; Lubrich-Birkner I; Dreyling KW; Schollmeyer P
Eur J Clin Invest; 1991 Feb; 21(1):47-52. PubMed ID: 1907554
[TBL] [Abstract][Full Text] [Related]
19. Treatment of anaemia resistant to conventional erythropoietin therapy with thymopentin in haemodialysis patients.
Raiola P; Manzo M; Saggese A; Tomasino G; Cicchella T; Rambaldi M; Pisano M; Lizza B; Perna AF
Nephrol Dial Transplant; 1995; 10 Suppl 6():48-50. PubMed ID: 8524495
[No Abstract] [Full Text] [Related]
20. Comparative pharmacokinetics of recombinant erythropoietin administered by the intravenous, subcutaneous, and intraperitoneal routes in continuous ambulatory peritoneal dialysis (CAPD) patients.
Boelaert JR; Schurgers ML; Matthys EG; Belpaire FM; Daneels RF; De Cre MJ; Bogaert MG
Perit Dial Int; 1989; 9(2):95-8. PubMed ID: 2488207
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
